Found: 5
Select item for more details and to access through your institution.
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 112, doi. 10.1007/s10637-015-0307-6
- By:
- Publication type:
- Article
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
- Published in:
- ISRN Oncology, 2012, p. 1, doi. 10.5402/2012/242850
- By:
- Publication type:
- Article
Tonabersat Inhibits Trigeminal Ganglion Neuronal-Satellite Glial Cell Signaling.
- Published in:
- Headache: The Journal of Head & Face Pain, 2009, v. 49, n. 1, p. 5, doi. 10.1111/j.1526-4610.2008.01262.x
- By:
- Publication type:
- Article
Neuron–Glia Signaling in Trigeminal Ganglion: Implications for Migraine Pathology.
- Published in:
- Headache: The Journal of Head & Face Pain, 2007, v. 47, n. 7, p. 1008, doi. 10.1111/j.1526-4610.2007.00854.x
- By:
- Publication type:
- Article